Endoscopy

Outlook on the Capsule Endoscopy Global Market to 2028 - Featuring Olympus, IntroMedic and CapsoVision Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 23, 2021
Medical Devices, Health, Colorectal cancer, Crohn's disease, USD, Colon, Infection, Growth, Diagnosis, Esophagus, Obscure, COVID-19, Inflammatory bowel disease, Endoscopy, Prevalence, Capsule, Degenerative disease, Capsule endoscopy, Dietary supplement, Medical imaging

In addition, the growing demand for accurate, faster, and precise diagnostic tools coupled with favorable government initiatives are some of the other factors boosting the market growth.

Key Points: 
  • In addition, the growing demand for accurate, faster, and precise diagnostic tools coupled with favorable government initiatives are some of the other factors boosting the market growth.
  • Based on the product, the capsule endoscopes segment dominated the market in 2020 and is anticipated to register a significant growth rate over the forecast period.
  • It is attributed to the rising utilization rates of capsule endoscopes for the screening of the esophagus, colon, and small intestine in recent years.
  • The pandemic of COVID-19 has significantly impacted the market majorly due to the rescheduling, postponement, or cancellation of elective surgeries.

Kanazawa University research: Endoscopy of a living cell on the nanoscale

Retrieved on: 
Thursday, December 23, 2021
HeLa, Kotaro Fukuma, Kanazawa University, AFM, Cell membrane, Map, Cell, National Institute of Advanced Industrial Science and Technology, Cell nucleus, 2D, Endoscopy, Science Advances, AIST, Research, Biology, National Institute, Microscope, Science

KANAZAWA, Japan, Dec. 23, 2021 /PRNewswire/ --Researchers at Kanazawa University report in Science Advances a new technique for visualizing the inside of a biological cell.

Key Points: 
  • KANAZAWA, Japan, Dec. 23, 2021 /PRNewswire/ --Researchers at Kanazawa University report in Science Advances a new technique for visualizing the inside of a biological cell.
  • The method is an extension of atomic force microscopy and offers the promise of studying nanoscale inner cell dynamics at high resolution in a non-destructive way.
  • A label-free, non-destructive method has now been developed by Takeshi Fukuma from Kanazawa University and colleagues: nanoendoscopy-AFM, a version of atomic-force microscopy that can be deployed within a living cell.
  • One molecule emits green fluorescence from a living cell, the other red fluorescence from (the nucleus of) a dead cell.

Kanazawa University research: Endoscopy of a living cell on the nanoscale

Retrieved on: 
Thursday, December 23, 2021
HeLa, Kotaro Fukuma, Kanazawa University, AFM, Cell membrane, Map, Cell, National Institute of Advanced Industrial Science and Technology, Cell nucleus, 2D, Endoscopy, Science Advances, AIST, Research, Biology, National Institute, Microscope, Science

KANAZAWA, Japan, Dec. 23, 2021 /PRNewswire/ --Researchers at Kanazawa University report in Science Advances a new technique for visualizing the inside of a biological cell.

Key Points: 
  • KANAZAWA, Japan, Dec. 23, 2021 /PRNewswire/ --Researchers at Kanazawa University report in Science Advances a new technique for visualizing the inside of a biological cell.
  • The method is an extension of atomic force microscopy and offers the promise of studying nanoscale inner cell dynamics at high resolution in a non-destructive way.
  • A label-free, non-destructive method has now been developed by Takeshi Fukuma from Kanazawa University and colleagues: nanoendoscopy-AFM, a version of atomic-force microscopy that can be deployed within a living cell.
  • One molecule emits green fluorescence from a living cell, the other red fluorescence from (the nucleus of) a dead cell.

Global Colorectal Cancer Screening Market (2021 - 2026): North America is Expected to Dominate the Market - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 22, 2021
Health, Oncology, Organic, Colorectal cancer, Genetic testing, FAP, Colonoscopy, Adoption, Centrul Național Media, Polyp, Lung cancer, Disease, Risk, Patient, Skin, Colon, Death, United States Preventive Services Task Force, Diagnosis, COVID-19, Research, Endoscopy, Incidence, Lancet, National, International Agency for Research on Cancer, HNPCC, Large intestine, Prevalence, Rectum, CAGR, Pharmaceutical industry, Medical imaging, Vaccine, Dietary supplement, Cancer, Growth

The "Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
  • The Colorectal Cancer Screening Market is expected to register a CAGR of 5.4% in the forecast period of 2021-2026.
  • The major factors for the growth of the colorectal cancer screening market include the advent of efficacious genetic tests, an increase in the prevalence of colorectal cancer, and increasing cancer prevention initiatives.
  • The risk of Colorectal Cancer is higher in people with a strong family history of colorectal cancer, i.e., inherited colon cancer syndromes.

Global Endoscopy Visualization Systems and Components Market Analysis and Forecast Model to 2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 21, 2021
Surgery, Health, Reading, Review, Market access, Epidemiology, Time, SWOT, General surgery, Technology, Investment, General officer, Internet, COVID-19, LIBOR market model, Strategic planning, Industry, Cystoscopy, Bronchoscopy, Reproduction, Component, Forecast model, Finger, CMO, Medical imaging, Retail, Risk management, Management, Endoscopy

The "Endoscopy Visualization Systems and Components (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Endoscopy Visualization Systems and Components (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering.
  • The model discusses in detail the impact of COVID-19 on Endoscopy Visualization Systems and Components market for the year 2020 and beyond.
  • Annualized total Endoscopy Visualization Systems and Components market revenue by segment and market outlooks from 2015-2030.
  • Track device sales in the global and country-specific Endoscopy Visualization Systems and Components market from 2015-2030.

FUJIFILM Healthcare Americas Corporation Awarded Exclusive Contract for Surgical C-Arm Systems from the U.S. Army and Defense Logistics Agency (DLA)

Retrieved on: 
Monday, December 20, 2021
Magnetic resonance imaging, GLOBE, Mammography, OEM, Unitary state, Diagnosis, Compliance, Endoscopy, Federation, Patient safety, Fujifilm, DLA, Solution, Enterprise imaging, Defense, Google Images, Laboratory, Achievement, Knowledge, Medical imaging, Pharmaceutical industry, United States Army

Lexington, Mass., USA, Dec. 20, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation , a leading provider of diagnostic imaging and medical informatics solutions, today announced that it has been awarded a 4-year contract for its innovative surgical C-arm systems from the U.S. Army and Defense Logistics Agency (DLA).

Key Points: 
  • Lexington, Mass., USA, Dec. 20, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation , a leading provider of diagnostic imaging and medical informatics solutions, today announced that it has been awarded a 4-year contract for its innovative surgical C-arm systems from the U.S. Army and Defense Logistics Agency (DLA).
  • Fujifilm is honored to be awarded another significant contract from the DLA this year, as it speaks to the confidence and level of trust military officials place in our cutting-edge technology, said Lou Cavallaro, Director, Government Business Sales, FUJIFILM Healthcare Americas Corporation.
  • In August 2021, the company was awarded a 10-year sole source contract for its innovative digital radiography (DR) systems from the U.S. Navy and Defense Logistics Agency (DLA).
  • FUJIFILM Healthcare Americas Corporation is a leading innovator in diagnostic and enterprise imaging solutions designed to meet the evolving needs of healthcare across prevention, diagnosis, and treatment.

Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features

Retrieved on: 
Thursday, December 16, 2021
Colon, Forward-looking statement, Hospital, U.S. Securities and Exchange Commission, Technology, Food, Solution, FDA, Intellectual property, Company, Diagnosis, Private Securities Litigation Reform Act, Suction, COVID-19, NASDAQ, Endoscopy, USPTO, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Patient, Security (finance), Patent, GLOBE, Maintenance, Colonoscopy, Medical imaging

11,185,625, which is titled, Colon cleaning system with automatic self-purging features.

Key Points: 
  • 11,185,625, which is titled, Colon cleaning system with automatic self-purging features.
  • We continue to actively secure IP protection around the key features of our Pure-Vu System.
  • Motus GI estimates that approximately 4.8 million inpatient colonoscopy procedures took place during 2021.
  • The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Fujifilm Launches New Device Aimed at Simplifying Endoscopic Lesion Extraction During the New York Society for Gastrointestinal Endoscopy 2021 Conference

Retrieved on: 
Tuesday, December 14, 2021
Colon, Hospital, Gastrointestinal tract, Food, Solution, FDA, Enterprise imaging, OEM, Magnetic resonance imaging, Doctor of Philosophy, Diagnosis, Thomas Jefferson University Hospital, EUS, Conference, Time, ESD, Endoscopy, Mammography, Fujifilm, Associate professor, Lifting, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Neoplasm, Knowledge, Gastroenterology, Laboratory, MD, GLOBE, Gastrointestinal Endoscopy, List of Medknow Publications academic journals, Medical imaging, Medical device

said Taisuke Fujita, Vice President, Endoscopy, FUJIFILM Healthcare Americas Corporation.

Key Points: 
  • said Taisuke Fujita, Vice President, Endoscopy, FUJIFILM Healthcare Americas Corporation.
  • With TRACMOTION, an endoscopist uses simple single-hand movements to control the distal end of the product, independent of the endoscopes movement.
  • TRACMOTION can hold tissue during ESD without complicated locking mechanisms, demonstrating additional efficiencies when used during this advanced procedure.
  • Fujifilms medical imaging portfolio includes solutions for digital radiography, mammography, computed tomography, magnetic resonance imaging, ultrasound, endoscopy, and endosurgery.

enlightenVue™ Receives Chinese Patent Covering Core Technology for its Single-Use Micro-endoscope Platform with Two Working Channels

Retrieved on: 
Wednesday, December 15, 2021
Biotechnology, Hardware, Surgery, General Health, Health, Medical Devices, Hospitals, Technology, Obstetrics, Endoscopy, Gynaecology, Nose, Patient, Patent, Elective surgery, Ear, Medical device

enlightenVue, Inc. announced today that China has granted the company a patent covering the core technology underlying its surgiVue single-use micro-endoscope platform.

Key Points: 
  • enlightenVue, Inc. announced today that China has granted the company a patent covering the core technology underlying its surgiVue single-use micro-endoscope platform.
  • The patented technology enables the endoscope for diagnostic and therapeutic applications in a single procedure through two working channels in a two-millimeter working diameter.
  • In addition, to the Chinese patent, there are four issued U.S. patents, including the core patent, with additional U.S. and international patents pending.
  • enlightenVue has developed a novel single-use micro-endoscope platform with the industrys smallest diameter (2mm) with multiple working channels, which can be used in a single procedure for both diagnostic and therapeutic interventions.

Global Cancer Diagnostics Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, December 13, 2021
Health, General Health, Hospital, Melanoma, FDA, Protein, Death, Company, GE Healthcare, Cancer, Magnetic resonance imaging, Diagnosis, Growth, Lung cancer, World, Biomarker, Colorectal cancer, National Cancer Institute, COVID-19, Breast cancer, Hoffmann-La Roche, Endoscopy, Abbott, NCI, NMR, BD (company), World Health Organization, WHO, Kidney cancer, Ovarian cancer, Lymphatic system, Liver cancer, MRI, Cervical cancer, Pancreatic cancer, Contraindication, Biopsy, Thermo Fisher Scientific, Medical imaging, Medical device, Dietary supplement

The "Cancer Diagnostics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cancer Diagnostics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Cancer diagnostics market is segmented into companion diagnostics and molecular diagnostics.
  • The cancer diagnostics market covered in this report is segmented by products into companion diagnostics, molecular diagnostics.
  • It is also segmented by end-user into cancer research institutes, diagnostic laboratories, hospitals, others; by method into biopsy, endoscopy, tumor biomarker tests, imaging and by application into cervical cancer, breast cancer, liver cancer, blood cancer, kidney cancer, colorectal cancer, pancreatic cancer, ovarian cancer, melanoma, others.